This is exemplified by the ATPase subunit SMARCA4, which is frequently inactivated by loss-of-function mutations or epigenetic silencing in non-small cell lung cancer (NSCLC) and other tumor types21–24. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.